Blood-borne assessment of stromal activation in esophageal adenocarcinoma to guide tocilizumab therapy: A randomized phase II proof-of-concept study (NCT04554771).
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Roos E. Pouw |
| Publication date | June 1, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |